Question 1

What is the catalog number for AZD-5153?

Accepted Answer

The catalog number for AZD-5153 is B2020-25.

Question 2

Is AZD-5153 in stock?

Accepted Answer

AZD-5153 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is AZD-5153 used for?

Accepted Answer

AZD-5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor with a bivalent binding mode. AZD-5153 ligates two bromodomains in BRD4 simultaneously. Displays cellular and antitumor activity in preclinical hematologic tumor models.

Question 4

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

AZD-5153

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Rno-miR-409a-3p inhibitor

Rno-miR-409a-3p inhibitor

NSE Polyclonal Antibody Bio Conjugated

NSE Polyclonal Antibody Bio Conjugated

DMEM Low Glucose With L- Alanyl -L-Glutamine And PS And Without Phenol Red 500ml

SPINK8, CT (SPINK8, Serine protease inhibitor Kazal-type 8) (Azide free) (HRP) discontinued